AI assistant
Sending…
Oncopeptides — Major Shareholding Notification 2024
May 17, 2024
3091_iss_2024-05-17_79b3dd9d-0e74-4cdd-bd0d-e7cfb0ee8e3c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Oncopeptides AB
Holder
HealthCap VIII, L.P.
Instrument
| Instrument | Ordinary shares |
|---|---|
| Before the transaction | |
| Shares | 3,786,307 |
| Voting rights | 3,786,307 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 17/05/2024 |
| Limit for number of shares | 10 % |
| Limit for number of votes | 10 % |
| After the transaction | |
| Quantity | |
| Shares | 27,296,255 |
| Directly held voting rights | 27,296,255 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 12.68494 % |
| Directly held voting rights | 12.90958 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 12.90958 % | 27,296,255 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 12.90958 % | 27,296,255 |
Group total holdings
Voting rights 27,296,255 Percentage of voting rights 12.90958
Notes (other relevant informations according to law)
The notifications are based on the number of shares and votes in Oncopeptides AB (publ) after the rights issue which ended on 3 May 2024. After the rights issue, assuming the number of shares amounts to 215,186,246 and the number of votes amounts to 211,441,841, as per data communicated by the Company on 6 May 2024.
Published
17/05/2024 14:42
Contact
Name Fabrice Bernhard Phone +4179 860 69 23 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 16